by Janneke de Haan | Jun 15, 2022 | Interview, News
Patient interview: TOM VAN DER WAL We interviewed Tom van der Wal from The Netherlands about his experiences with immunotherapy. Tom has Multiple Myeloma (Kahler) and was diagnosed in 2016, treated in VUmc Amsterdam, and was in remission in 2017. Unfortunately, the...
by Janneke de Haan | Jun 15, 2022 | Interview, News
Meet the partner: University of Cambridge Kevin Brindle is Professor of Biomedical Magnetic Resonance in the Department of Biochemistry at the University of Cambridge and a Senior Group Leader in the Cancer Research UK Cambridge Institute. The current focus of his...
by Janneke de Haan | Jun 6, 2022 | Publications
Novel PET Imaging of Inflammatory Targets and Cells for the Diagnosis and Monitoring of Giant Cell Arteritis and Polymyalgia Rheumatica ABSTRACT Introduction Giant cell arteritis (GCA) and polymyalgia rheumatica (PMR) are two interrelated inflammatory diseases...
by Janneke de Haan | Apr 23, 2022 | Publications
Phenotypic, transcriptomic and functional profiling reveal reduced activation thresholds of CD81 T cells in giant cell arteritis ABSTRACT Objectives Evidence from temporal artery tissue and blood suggests involvement of CD8þ T cells in the pathogenesis of GCA,...
by Janneke de Haan | Apr 23, 2022 | Publications
Expanding Theranostic Radiopharmaceuticals for Tumor Diagnosis and Therapy ABSTRACT Introduction Radioligand theranostics (RT) in oncology use cancer-type specific biomarkers and molecular imaging (MI), including positron emission tomography (PET),...
Recent Comments